Literature DB >> 6924749

Changes of post-transcriptional modification of wye base in tumor-specific tRNAPhe.

Y Kuchino, E Borek, D Grunberger, J F Mushinski, S Nishimura.   

Abstract

Nucleotide sequences of normal mouse liver tRNAPhe and tumor-specific tRNAPhes isolated from Ehrlich ascites tumor and neuroblastoma cells were examined by post-labeling techniques. The results showed that their sequences are identical, except for changes in post-transcriptional modifications that are located in the anticodon region. Normal mouse liver tRNAPhe contained Cm32, Gm34 and YOH37. On the other hand, tumor-specific tRNAPhes were found in one of two possible configurations: 1) Cm32, Gm34 and Y*OH37 (under-modified YOH) or 2) C32, G34 and m1G37. The ratio of the two forms of tRNAPhes differed in different tumor cells; Ehrlich ascites tumor tRNAPhe had mainly Y*OH-containing tRNAPhe whereas neuroblastoma tRNAPhe has predominantly m1G-containing tRNAPhe. It was concluded that tumor-specific tRNAPhes are products of different extents of modification, rather than of new tRNA transcription.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6924749      PMCID: PMC326932          DOI: 10.1093/nar/10.20.6421

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  Deficiency of the Y base in a hepatoma phenylalanine tRNA.

Authors:  D Grunberger; I B Weinstein; J F Mushinski
Journal:  Nature       Date:  1975-01-03       Impact factor: 49.962

2.  Relation of cell type and cell density to the degree of post-transcriptional modification of tRNALys and tRNAPhe.

Authors:  J R Katze
Journal:  Biochim Biophys Acta       Date:  1975-11-04

3.  Sequence studies on tRNAPhe from placenta: comparison with known sequences of tRNAPhe from other normal mammalian tissues.

Authors:  B A Roe; M P Anandaraj; L S Chia; E Randerath; R C Gupta; K Randerath
Journal:  Biochem Biophys Res Commun       Date:  1975-10-27       Impact factor: 3.575

4.  The primary structure of two mammalian tRNAs Phe: identity of calf liver and rabbit liver tRNAs Phe.

Authors:  G Keith; J P Ebel; G Dirheimer
Journal:  FEBS Lett       Date:  1974-11-01       Impact factor: 4.124

5.  Isolation and structure determination of the fluorescent base from bovine liver phenylalanine transfer ribonucleic acid.

Authors:  S H Blobstein; D Grunberger; I B Weinstein; K Nakanishi
Journal:  Biochemistry       Date:  1973-01-16       Impact factor: 3.162

6.  Small ribonucleic acids of Escherichia coli. I. Characterization by polyacrylamide gel electrophoresis and fingerprint analysis.

Authors:  T Ikemura; J E Dahlberg
Journal:  J Biol Chem       Date:  1973-07-25       Impact factor: 5.157

7.  The primary structure of rabbit liver tRNA Phe and its comparison with known tRNA Phe sequences.

Authors:  G Keith; F Picaud; J Weissenbach; J P Ebel; G Petrissant; G Dirheimer
Journal:  FEBS Lett       Date:  1973-05-01       Impact factor: 4.124

8.  Fractionation of rat liver transfer ribonucleic acid. Isolation of tyrosine, valine, serine, and phenylalanine transfer ribonucleic acids and their coding properties.

Authors:  S Nishimura; I B Weinstein
Journal:  Biochemistry       Date:  1969-03       Impact factor: 3.162

9.  Abundance of tRNAPhe lacking the peroxy Y-base in mouse neuroblastoma.

Authors:  R Salomon; D Giveon; Y Kimhi; U Z Littauer
Journal:  Biochemistry       Date:  1976-11-30       Impact factor: 3.162

10.  Genes for neuronal properties expressed in neuroblastoma x L cell hybrids.

Authors:  J Minna; P Nelson; J Peacock; D Glazer; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1971-01       Impact factor: 11.205

View more
  26 in total

Review 1.  tRNA biology charges to the front.

Authors:  Eric M Phizicky; Anita K Hopper
Journal:  Genes Dev       Date:  2010-09-01       Impact factor: 11.361

2.  Defects in tRNA Anticodon Loop 2'-O-Methylation Are Implicated in Nonsyndromic X-Linked Intellectual Disability due to Mutations in FTSJ1.

Authors:  Michael P Guy; Marie Shaw; Catherine L Weiner; Lynne Hobson; Zornitza Stark; Katherine Rose; Vera M Kalscheuer; Jozef Gecz; Eric M Phizicky
Journal:  Hum Mutat       Date:  2015-09-10       Impact factor: 4.878

3.  Biosynthesis of wybutosine, a hyper-modified nucleoside in eukaryotic phenylalanine tRNA.

Authors:  Akiko Noma; Yohei Kirino; Yoshiho Ikeuchi; Tsutomu Suzuki
Journal:  EMBO J       Date:  2006-04-27       Impact factor: 11.598

Review 4.  Distribution and frequencies of post-transcriptional modifications in tRNAs.

Authors:  Magdalena A Machnicka; Anna Olchowik; Henri Grosjean; Janusz M Bujnicki
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

5.  Natural UAG suppressor glutamine tRNA is elevated in mouse cells infected with Moloney murine leukemia virus.

Authors:  Y Kuchino; H Beier; N Akita; S Nishimura
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Characterization of Novikoff hepatoma small RNAs homologous to repetitive DNAs.

Authors:  R Reddy; D Henning; D Suh
Journal:  Mol Cell Biochem       Date:  1988-02       Impact factor: 3.396

7.  tRNAmodpred: A computational method for predicting posttranscriptional modifications in tRNAs.

Authors:  Magdalena A Machnicka; Stanislaw Dunin-Horkawicz; Valérie de Crécy-Lagard; Janusz M Bujnicki
Journal:  Methods       Date:  2016-03-23       Impact factor: 3.608

8.  tRNAHis 5-methylcytidine levels increase in response to several growth arrest conditions in Saccharomyces cerevisiae.

Authors:  Melanie A Preston; Sonia D'Silva; Yoshiko Kon; Eric M Phizicky
Journal:  RNA       Date:  2012-12-18       Impact factor: 4.942

9.  Yeast Trm7 interacts with distinct proteins for critical modifications of the tRNAPhe anticodon loop.

Authors:  Michael P Guy; Brandon M Podyma; Melanie A Preston; Hussam H Shaheen; Kady L Krivos; Patrick A Limbach; Anita K Hopper; Eric M Phizicky
Journal:  RNA       Date:  2012-08-21       Impact factor: 4.942

10.  tRNA gene copy number variation in humans.

Authors:  James R Iben; Richard J Maraia
Journal:  Gene       Date:  2013-12-14       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.